Table 3 The novel predictions of DCPred2
Rank | Drug components | P-value | Common targets | Reported effective combinations? |
|---|---|---|---|---|
10 | DB00275; DB00177 Olmesartan; Valsartan | 4.35E-05 | AGTR1 | No |
11 | DB00275; DB00966 Olmesartan; Telmisartan | 4.35E-05 | AGTR1 | No |
12 | DB00177; DB00966 Valsartan; Telmisartan | 4.35E-05 | AGTR1 | No |
13 | DB01248; DB00441 Docetaxel; Gemcitabine | 4.83E-05 | None | Yes |
14 | DB00526; DB01248 Oxaliplatin; Docetaxel | 4.83E-05 | None | No |
22 | DB00398; DB00112 Sorafenib; Bevacizumab | 0.000130406 | None | Yes |
23 | DB00741; DB00860 Hydrocortisone; Prednisolone | 0.000130406 | None | No |
24 | DB01132; DB00412 Pioglitazone; Rosiglitazone | 0.000130406 | PPARG | No |
25 | DB00480; DB00987 Lenalidomide; Cytarabine | 0.000130406 | None | No |
26 | DB00398; DB00002 Sorafenib; Cetuximab | 0.000130406 | None | No |
27 | DB00564; DB00776 Carbamazepine; Oxcarbazepine | 0.000130406 | SCN5A | No |
34 | DB00762; DB01101 Irinotecan; Capecitabine | 0.000260813 | None | Yes |
35 | DB00480; DB01041 Lenalidomide; Thalidomide | 0.000260813 | PTGS2 | Yes |